Background: Although laparoscopy may provide more detailed morphological and histological information about peritoneal damage, its significance in patients with long vintage of peritoneal dialysis (PD) is not elucidated. Methods: Findings in 12 patients with PD vintage of 7.3 (5.0-8.4) years who had undergone laparoscopy between 2007 and 2011 were reviewed. Macroscopic (peritoneal change, hypervascular change, adhesion, encapsulation) and histopathological peritoneal findings (interstitial fibrosis, microvascular change, fibrin deposition, inflammatory cell infiltration) were scored and summed as Macro-total score (Macro-TS) and Micro-total score (Micro-TS), respectively. Factors associated with these scores and the relationship between these scores were investigated. Results: Neither Macro-TS nor Micro-TS were related to PD vintage (p = 0.069 and p = 0.769, respectively); moreover, Macro-TS varied from patient to patient regardless of similar PD vintage. However, Macro-TS showed a significant association with duration of acidic dialysate (p = 0.003). Conclusion: Macroscopic and microscopic findings via laparoscopy may help the assessment of peritoneal damage in patients with long PD vintage.

Keywords:
Acidic dialysate, Encapsulating peritoneal sclerosis , Laparoscopy, Peritoneal dialysis, Peritoneal equilibration test
1.
Cueto-Manzano AM, Rojas-Campos E: Status of renal replacement therapy and peritoneal dialysis in Mexico. Perit Dial Int 2007;27:142-148.
2.
Yu AW, Chau KF, Ho YW, Li PK: Development of the ‘peritoneal dialysis first' model in Hong Kong. Perit Dial Int 2007;27(suppl 2):S53-S55.
3.
Japan Society for Dialysis Therapy Committee for Renal Data Registry. An overview of regular dialysis treatment in Japan as of December 31, 2013; JDST website: http://www.jsdt.or.jp/.
4.
Kawanishi H, Kawaguchi Y, Fukui H, Hara S, Imada A, Kubo H, Kin M, Nakamoto M, Ohira S, Shoji T: Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis 2004;44:729-737.
5.
Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa K: Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis 1996;28:420-427.
6.
Brown MC, Simpson K, Kerssens JJ, Mactier RA; Scottish Renal Registry: Encapsulating peritoneal sclerosis in the new millennium: a national cohort study. Clin J Am Soc Nephrol 2009;4:1222-1229.
7.
Summers AM, Clancy MJ, Syed F, Harwood N, Brenchley PE, Augustine T, Riad H, Hutchison AJ, Taylor P, Pearson R, Gokal R: Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int 2005;68:2381-2388.
8.
Kawaguchi Y, Saito A, Kawanishi H, Nakayama M, Miyazaki M, Nakamoto H, Tranaeus A: Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int 2005;25(suppl 4):S83-S95.
9.
Honda K, Oda H: Pathology of encapsulating peritoneal sclerosis. Perit Dial Int 2005;25(suppl 4):S19-S29.
10.
Honda K, Hamada C, Nakayama M, Miyazaki M, Sherif AM, Harada T, Hirano H; Peritoneal Biopsy Study Group of the Japanese Society for Peritoneal Dialysis: Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology. Clin J Am Soc Nephrol 2008;3:720-728.
11.
Braun N, Alscher MD, Kimmel M, Amann K, Büttner M: Encapsulating peritoneal sclerosis - an overview. Nephrol Ther 2011;7:162-171.
12.
Yamamoto T, Nagasue K, Okuno S, Yamakawa T: The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis. Perit Dial Int 2010;30:343-352.
13.
Otsuka Y, Nakayama M, Ikeda M, Sherif AM, Yokoyama K, Yamamoto H, Kawaguchi Y: Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis. Clin Exp Nephrol 2005;9:315-319.
14.
Araki Y, Hataya H, Tanaka Y, Fukuzawa R, Ikeda M, Kawamura K, Honda M: Long-term peritoneal dialysis is a risk factor of sclerosing encapsulating peritonitis for children. Perit Dial Int 2000;20:445-451.
15.
Kawanishi H, Fujimori A, Tsuchida K, Takemoto Y, Tomo T, Minakuchi J, Yamamoto T, Kim M, Numata A, Choh S, Naito H; Peritoneal Effluent Study Group Japan: Markers in peritoneal effluent for withdrawal from peritoneal dialysis: multicenter prospective study in Japan. Adv Perit Dial 2005;21:134-138.
16.
Hirahara I, Inoue M, Okuda K, Ando Y, Muto S, Kusano E: The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis - a multicentre study in Japan. Nephrol Dial Transplant 2007;22:560-567.
17.
Iwamoto N, Ono T: EPS decreasing? - Laparoscopic study (in Japanese). Kidney and Dialysis 2009;66:18-22.
18.
Smith L, Collins JF, Morris M, Teele RL: Sclerosing encapsulating peritonitis associated with continuous ambulatory peritoneal dialysis: surgical management. Am J Kidney Dis 1997;29:456-460.
19.
Kropp J, Sinsakul M, Butsch J, Rodby R: Laparoscopy in the early diagnosis and management of sclerosing encapsulating peritonitis. Semin Dial 2009;22:304-307.
20.
Kawanishi H, Watanabe H, Moriishi M, Tsuchiya S: Successful surgical management of encapsulating peritoneal sclerosis. Perit Dial Int 2005;25(suppl 4):S39-S47.
21.
Davies SJ, Phillips L, Naish PF, Russell GI: Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001;12:1046-1051.
22.
Finkelstein F, Healy H, Abu-Alfa A, Ahmad S, Brown F, Gehr T, Nash K, Sorkin M, Mujais S: Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol 2005;16:546-554.
23.
Kawanishi H, Shintaku S, Shishida M, Morrishi M, Tsuchiya S, Dohi K: A case of encapsulating peritoneal sclerosis suspected to result from the use of icodextrin peritoneal solution. Adv Perit Dial 2009;25:45-49.
24.
Szetto CC, Chow KM, Lam CW, Leung CB, Kwan BC, Chung KY, Law MC, Li PK: Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products - a 1-year randomized control trial. Nephrol Dial Transplant 2007;22:552-559.
25.
Lee HY, Choi HY, Park HC, Seo BJ, Do JY, Yun SR, Song HY, Kim YH, Kim YL, Kim DJ, Kim YS, Kim MJ, Shin SK: Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome. Nephrol Dial Transplant 2006;21:2893-2899.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.